Home >> Signaling Pathways >> Tyrosine Kinase >> Insulin Receptor

Insulin Receptor

Insulin receptor is a transmembrane receptor tyrosine kinase that mediates the insulin function and involved in the regulation of cell differentiation, growth and metabolism etc.

Products for  Insulin Receptor

  1. Cat.No. Product Name Information
  2. GC50157 6bK Insulin degrading enzyme (IDE) inhibitor 6bK  Chemical Structure
  3. GC31371 AGL-2263 An inhibitor of IGF-1R AGL-2263  Chemical Structure
  4. GC64683 AVJ16 AVJ16 is a member of the insulin-like growth factor 2 mRNA-binding protein family. AVJ16 regulates protein translation by binding to the mRNAs of certain genes. AVJ16  Chemical Structure
  5. GC17773 BMS-536924

    IR/IGF-1R inhibitor

    BMS-536924  Chemical Structure
  6. GC16712 BMS-754807 IGF-1R/InsR inhibitor,potent and selective BMS-754807  Chemical Structure
  7. GC45789 Ceritinib-d7 An internal standard for the quantification of ceritinib Ceritinib-d7  Chemical Structure
  8. GC62712 DA-JC4 DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways. DA-JC4  Chemical Structure
  9. GC14905 Demethylasterriquinone B1

    An insulin receptor (IR) activator

    Demethylasterriquinone B1  Chemical Structure
  10. GA21893 Gastric Inhibitory Polypeptide (1-30) amide (porcine) Gastric Inhibitory Polypeptide (1-30) amide (porcine) is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42). Gastric Inhibitory Polypeptide (1-30) amide (porcine)  Chemical Structure
  11. GA21894 Gastric Inhibitory Polypeptide (3-42) (human) Gastric Inhibitory Polypeptide (3-42) (human) acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo. Gastric Inhibitory Polypeptide (3-42) (human)  Chemical Structure
  12. GC61569 GIP (1-30) amide, porcine TFA GIP (1-30) amide, porcine TFA is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42). GIP (1-30) amide, porcine TFA  Chemical Structure
  13. GC60175 GIP (1-30) amide,Human acetate GIP (1-30) amide,human acetate is a glucose-dependent insulinotropic polypeptide (GIP) fragment. GIP (1-30) amide,Human acetate  Chemical Structure
  14. GC61741 GIP, human TFA GIP, human TFA, a peptide hormone consisting of 42 amino acids, is a stimulator of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. GIP, human TFA  Chemical Structure
  15. GC12273 GSK1838705A IGF-IR/IR/ALK inhibitor, ATP-competitive GSK1838705A  Chemical Structure
  16. GC14654 HNGF6A increases glucose stimulated insulin secretion and glucose metabolism HNGF6A  Chemical Structure
  17. GC13988 HNMPA cell impermeable tyrosine kinase inhibitor HNMPA  Chemical Structure
  18. GC18093 Insulin (human) recombinant expressed in yeast

    Endogenous insulin receptor agonist

    Insulin (human) recombinant expressed in yeast  Chemical Structure
  19. GC67998 Insulin degludec Insulin degludec  Chemical Structure
  20. GC31526 Insulin levels modulator Insulin levels modulator could be used to treat diabetes. Insulin levels modulator  Chemical Structure
  21. GC31303 Insulin(cattle) (Insulin from bovine pancreas) Insulin cattle (Insulin from bovine pancreas) is a two-chain polypeptide hormone produced in vivo in the pancreatic β cells. Insulin(cattle) (Insulin from bovine pancreas)  Chemical Structure
  22. GN10497 Kaempferitrin Kaempferitrin  Chemical Structure
  23. GC10626 KU14R KU14R  Chemical Structure
  24. GC14552 LDK378 LDK378 (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. LDK378  Chemical Structure
  25. GC17452 LDK378 dihydrochloride LDK378 dihydrochloride  Chemical Structure
  26. GC15749 Linsitinib IGF1R/IR inhibitor,potent and novel Linsitinib  Chemical Structure
  27. GC61516 MID-1 MID-1 is a disruptor of MG53-IRS-1 (Mitsugumin 53-insulin receptor substrate-1) interaction. MID-1  Chemical Structure
  28. GC13525 MRS 4062 triethylammonium salt P2Y4 receptor agonist MRS 4062 triethylammonium salt  Chemical Structure
  29. GC15936 MSDC-0160 mTOT-modulating insulin sensitizer MSDC-0160  Chemical Structure
  30. GC64431 MSDC-0602K MSDC-0602K (Azemiglitazone potassium), a PPARγ-sparing thiazolidinedione (Ps-TZD), binds to PPARγ with the IC50 of 18.25 μM. MSDC-0602K  Chemical Structure
  31. GC12712 NT157 IRS-1/2 inhibitor, inhibits IGF-1R and STAT3 signaling pathway NT157  Chemical Structure
  32. GC69599 NT219

    NT219 is an effective dual inhibitor of insulin receptor substrate 1/2 (IRS1/2) and STAT3. IRS1/2 and STAT3 are major signaling pathways regulated by various oncogenes. NT219 affects the degradation of IRS1/2 and inhibits the phosphorylation of STAT3. NT219 has potential for researching cancer diseases.

    NT219  Chemical Structure
  33. GC12963 NVP-AEW541 IGF-IR inhibitor, novel, potent and selective NVP-AEW541  Chemical Structure
  34. GN10784 Rhoifolin Rhoifolin  Chemical Structure
  35. GC61550 S961 acetate S961 acetate is an high-affinity and selective insulin receptor (IR) antagonist with IC50s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively. S961 acetate  Chemical Structure
  36. GC39189 S961 TFA S961 TFA is an high-affinity and selective insulin receptor (IR) antagonist with IC50s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively. S961 TFA  Chemical Structure
  37. GC61957 SU4984 SU4984 is a protein tyrosine kinase inhibitor, with an IC50 of 10-20 μM for fibroblast growth factor receptor 1 (FGFR1). SU4984 is also inhibits platelet-derived growth factor receptor, and insulin receptor. SU4984 can be used for the research of cancer. SU4984  Chemical Structure
  38. GC16821 TAE226(NVP-TAE226) TAE226(NVP-TAE226) (TAE226) is a potent and ATP-competitive dual FAK and IGF-1R inhibitor with IC50s of 5.5 nM and 140 nM, respectively. TAE226(NVP-TAE226)  Chemical Structure

37 Item(s)

per page

Set Descending Direction